The Discounted Cash Flow (DCF) valuation of Trillium Therapeutics Inc (TRIL.TO) is 0.79 CAD. With the latest stock price at 23.33 CAD, the upside of Trillium Therapeutics Inc based on DCF is -96.6%.
| Range | Selected | |
| WACC / Discount Rate | 8.6% - 10.7% | 9.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 0.65 - 0.85 | 0.79 |
| Upside | -97.2% - -96.4% | -96.6% |